Literature DB >> 25727235

A Review and Proposed Approach to the Neutrophilic Dermatoses of Childhood.

Kate Webb1,2, Carol Hlela1,2, H Francois Jordaan3, Sara Suliman4, Thomas Scriba4, Dan Lipsker5, Chris Scott1.   

Abstract

Neutrophilic dermatoses (NDs) are inflammatory skin conditions that are not associated with infection. The classification and clinical approach to these conditions in children is poorly described. This review classifies these conditions into five nosological subtypes: Sweet's syndrome, pyoderma gangrenosum, aseptic pustules, neutrophilic urticarial dermatoses, and Marshall's syndrome. In addition, we review the various secondary diseases that need to be excluded in the clinical management of the NDs of childhood, with a focus on the autoinflammatory conditions that the reader may not be familiar with. We propose a practical clinical approach to these disorders.
© 2015 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25727235     DOI: 10.1111/pde.12502

Source DB:  PubMed          Journal:  Pediatr Dermatol        ISSN: 0736-8046            Impact factor:   1.588


  3 in total

Review 1.  Urticaria and Angioedema: an Update on Classification and Pathogenesis.

Authors:  Susanne Radonjic-Hoesli; Kathrin Scherer Hofmeier; Sara Micaletto; Peter Schmid-Grendelmeier; Andreas Bircher; Dagmar Simon
Journal:  Clin Rev Allergy Immunol       Date:  2018-02       Impact factor: 8.667

2.  Sweet Syndrome in an Adolescent Patient With Differentiation Syndrome Secondary to Promyelocytic Leukemia Treatment With All-Trans Retinoic Acid.

Authors:  Jorge Luis Ramirez Melo; Rosa Margarita Cruz Osorio; Jessica Santoyo Cueva; Fernando Sanchez Zubieta; Pablo Alejandro Chavez; Luis Tonatiuh Fernandez Mendoza; Felipe de Jesus Bustos Rodriguez; Christian David Burbano Figueroa; Johana Alexandra Burbano Figueroa
Journal:  J Med Cases       Date:  2021-12-02

3.  Neonatal lupus erythematosus or Sweet syndrome?

Authors:  Zandile Spengane; Carol Hlela; Komala Pillay
Journal:  JAAD Case Rep       Date:  2018-09-14
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.